Prevalence of congenital adrenal hyperplasia among sudden infant death in the Czech Republic and Austria
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
This study aimed to estimate the number of infants who died of unrecognized congenital adrenal hyperplasia (CAH) in Austria and the Czech Republic within the past 13 years, before the introduction of adequate neonatal screening. The study was based on retrospective analysis of neonatal screening cards of 242 infants who died suddenly between 7 days and 12 months of age and whose cause of death could not be identified. 17-hydroxyprogesterone (17-OHP) was measured by fluoroimmunoassay and positive samples were subsequently genotyped. Three infants out of 242 may have had unrecognized CAH due to CYP21 (steroid 21-hydroxylase) gene defect. Their newborn 17-OHP levels and CYP21 genotypes were 706 nmol/l and del/conv//del/conv, 53 nmol/l and I2//I2, and 811 nmol/l and I2//Gln318stop, respectively. CAH due to CYP21 defect can lead to sudden unexpected death without prior symptoms typical for the condition. Hence, newborn screening would have prevented these deaths had it been available. In addition, we have shown that the I2 point mutation that is expected to lead to simple virilizing form may lead to a fatal outcome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A retrospective analysis of neonatal dried blood samples that were not screened for CAH from cases of sudden infant death in the Czech Republic and Austria identified three genotypically confirmed cases of classic CAH among 242 samples screened (49).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [49]
Citations
Cites
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency*
White, P. C., & Speiser, P. W. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.3.0398 · Cited by 1,432
Global Disorders of Sex Development Update since 2006: Perceptions, Approach and Care
Lee, P. A., Nordenström, A., Houk, C. P., Ahmed, S. F., Auchus, R., Baratz, A., Baratz Dalke, K., Liao, L.-M., Lin-Su, K., Looijenga 3rd, L. H. J., et al. (2016) · Hormone Research in Paediatrics · doi:10.1159/000442975 · Cited by 1,273
Krous, H. F., Beckwith, J. B., Byard, R. W., Rognum, T. O., Bajanowski, T., Corey, T., Cutz, E., Hanzlick, R., Keens, T. G., & Mitchell, E. A. (2004) · Pediatrics · doi:10.1542/peds.114.1.234 · Cited by 844 · cited 2×
“NA Not available, 17-OHP 17-hydroxyprogesterone a Category of SIDS corresponds to the criteria approved at International SIDS Meeting in San Diego [6] Given concentrations of 17-OHP were from native cards, corrected for storage time [12] CYP21 was genotyped to detect nine most prevalent disease-causing gene defects.”
Pang, S., Wallace, M. A., Hofman, L., Thuline, H. C., Dorche, C., Lyon, I. C. T., Dobbins, R. H., Kling, S., Fujieda, K., & Suwa, S. (1988) · Journal of Urology · doi:10.1016/s0022-5347(17)42164-1 · Cited by 392 · cited 1×
“higher incidence of CAH detected by newborn screening when compared to previous case surveys of clinically detected patients [8].”
Therrell, B. L., Berenbaum, S. A., Manter-Kapanke, V., Simmank, J., Korman, K., Prentice, L., Gonzalez, J., & Gunn, S. (1998) · Pediatrics · doi:10.1542/peds.101.4.583 · Cited by 344 · cited 1×
“One such case was identified retrospectively 4 years after the child’s death [ 10 ].”
Pang, S., Wallace, M. A., Hofman, L. F., Thuline, H. C., Dorche, C., Lyon, I. C. T., Dobbins, R. H., Kling, S., Fujieda, K., & Suwa, S. (1988) · PEDIATRICS · doi:10.1542/peds.81.6.866 · Cited by 191
Olgemöller, B., Roscher, A. A., Liebl, B., & Fingerhut, R. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021732 · Cited by 124 · cited 1×
“Positive samples from premature babies were re-evaluated with birthweight and age-adjusted cut-off levels [7].”
Fitness, J., Dixit, N., Webster, D., Torresani, T., Pergolizzi, R., Speiser, P. W., & Day, D. J. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.3.5550 · Cited by 103 · cited 1×
“Gene-specific PCR and ligasemediated mutation detection were used as described previously [1].”
MethodSelf-citationEvaluation of Neonatal Screening for Congenital Adrenal Hyperplasia
Honour, J. W., & Torresani, T. (2001) · Hormone Research in Paediatrics · doi:10.1159/000049997 · Cited by 57 · cited 1×
“one (17-OHP) has been introduced in some countries [3].”
Self-citationKovacs, J. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.7.2958 · Cited by 52 · cited 2×
“Hence, the number of deceased children is lower in comparison to the mortality rate assessed by the MEWPE study group predicting about 2–3 missed CAH cases per 400,000 live births [5].”
Self-citationNeonatal Screening Program for Congenital Adrenal Hyperplasia: Adjustments to the Recall Protocol
Gruñeiro-Papendieck, L., Prieto, L., Chiesa, A., Bengolea, S., Bossi, G., & Bergadá, C. (2001) · Hormone Research in Paediatrics · doi:10.1159/000050012 · Cited by 50 · cited 1×
“One case of salt-wasting form of CAH in a girl with low-grade virilization (Prader 2) missed on clinical examination has been reported previously [2].”
Torres, N., Mello, M. P., Germano, C. M. R., Elias, L. L. K., Moreira, A. C., & Castro, M. (2003) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2003001000006 · Cited by 45 · cited 1×
“Female salt wasters are typically born with ambiguous genitalia (Prader III and higher, according to [11]) and are consequently more likely to be diagnosed prior to the onset of any adrenal crisis.”
Congenital adrenal hyperplasia: phenotype and genotype.
Hughes, I. A. (2002) · PubMed · Cited by 29
Stability of 17α-Hydroxyprogesterone in Dried Blood Spots after Autoclaving and Prolonged Storage
Török, D., Mühl, A., Votava, F., Heinze, G., Sólyom, J., Crone, J., Stöckler‐Ipsiroglu, S., & Waldhauser, F. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.2.370 · Cited by 26
Self-citationTörök, D., Mühl, A., Votava, F., Heinze, G., Sólyom, J., Crone, J., Stöckler‐Ipsiroglu, S., & Waldhauser, F. (2002) · PubMed · Cited by 23
Self-citationCardiac arrest in an infant with congenital adrenal hyperplasia
Ruppen, W., Hagenbuch, N., Jöhr, M., & Christen, P. (2002) · Acta Anaesthesiologica Scandinavica · doi:10.1034/j.1399-6576.2003.470120.x · Cited by 15 · cited 1×
“If unrecognized and untreated, the adrenal crisis may be life-threatening due to hyperkalemia [9] or dehydration, which mostly occurs during the first weeks of life [4].”
Cited by
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468
“confirmed cases of classic CAH among 242 samples screened (49).”
Speiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
PW, S., W, A., RJ, A., LS, B., GS, C., DP, M., HFL, M.-B., WL, M., MH, M., SE, O., et al. (2019) · Yearbook of Paediatric Endocrinology · doi:10.1530/ey.16.8.5 · Cited by 300
Neonatal screening for congenital adrenal hyperplasia
White, P. C. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.148 · Cited by 240
“Indeed, a retrospective analysis of neonatal blood samples from cases of unexplained sudden infant death in the Czech Republic and Austria identified 3 genotype-proven cases of classic CAH among 242 samples screened”
Population Screening for Genetic Disorders in the 21st Century: Evidence, Economics, and Ethics
Grosse, S. D., Rogowski, W. H., Ross, L. F., Cornel, M. C., Dondorp, W. J., & Khoury, M. J. (2010) · Public Health Genomics · doi:10.1159/000226594 · Cited by 138
Metadata
- Authors
- Strnadová, K. A., Votava, F., Lebl, J., Mühl, A., Item, C., Bodamer, O. A., Torresani, T., Bouška, I., Waldhauser, F., & Sperl, W.
- Affiliations
- Charles University (CZ)
- Medical University of Vienna (AT)
- University Children's Hospital Zurich (CH)
- Paracelsus Medical University (AT)
- Corresponding author
- Strnadová, Kristina A.
- Venue
- European Journal of Pediatrics
- Published
- 2006-09-22
- Volume
- 166
- Issue
- 1
- Pages
- 1-4
- ISSN
- 0340-6199 (ISSN-L)
- 1432-1076
- OpenAlex
- W2008937365
- Cited by
- 30
- References
- 16
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 4 · 2021: 2 · 2020: 1 · 2019: 4 · 2018: 3 · 2017: 1 · 2015: 1 · 2012: 3
- FWCI
- 0.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- European Journal of Pediatrics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- congenital adrenal hyperplasia, sudden infant death syndrome, 17-hydroxyprogesterone, CYP21, 21-hydroxylase deficiency, newborn screening, fatal outcome, genotype-phenotype correlation, Czech Republic, Austria
- MeSH terms
- Adrenal Hyperplasia, Congenital, Austria, Female, Humans, Infant, Infant, Newborn, Male, Sudden Infant Death, Prevalence, Neonatal Screening, Czech Republic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.